Phinomics is unlocking a hidden layer of biology—circular DNA and cryptic proteins—to power the next generation of AI in precision medicine. While others models train on a static, 1-D linear genome, we see a 3D, dynamic ecosystem of disease-driving elements. Our platform decodes and quantifies these overlooked signals and integrates them into high-resolution, multimodal maps of disease biology—connecting circular DNA with expression, epigenetics, and clinical outcomes. But the real breakthrough isn’t just better data—it’s what we do with it. Phinomics trains AI on orthogonal, causal, and clinically validated signals that go far beyond conventional inputs. The result is biological intelligence that understands disease from the inside out, powering new models for prediction, precision, and cure. That’s Phinomics. The lens into biology no one else has and the data engine that will power the future of precision medicine.
| Website | https://www.phinomics.com |
| Employees | 12 (7 on RocketReach) |
| Phone | +1 858-792-8984 |
| Industry | Biotechnology |
| Keywords | Cancer Research, Cancer Diagnostics, Drug Resistance, Immune Response, Genomics, Dna Analysis, Bioinformatics, Drug Discovery, Biotechnology, Precision Medicine, Machine Learning, Data Analysis, Molecular Biology, Life Sciences, Data Science, Scientific Data, Big Data |
| Competitors | Microsoft, IBM, Oracle, SAP, SAS, Domo, Tableau, Qlik, TIBCO Streaming, Looker +42 more (view full list) |
Looking for a particular Phinomics employee's phone or email?
Guido Mathews is the Chief Business Officer of Phinomics.
7 people are employed at Phinomics.